Ensign Peak Advisors, Inc Pacira Bio Sciences, Inc. Transaction History
Ensign Peak Advisors, Inc
- $58.8 Billion
- Q3 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 18,320 shares of PCRX stock, worth $435,649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,320
Previous 21,020
12.84%
Holding current value
$435,649
Previous $522,000
9.58%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
48.9MCall Options Held
118KPut Options Held
63.7K-
Black Rock Inc. New York, NY8.01MShares$190 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$124 Million0.0% of portfolio
-
Doma Perpetual Capital Management LLC Miami, FL2.7MShares$64.2 Million23.38% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$51.4 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.14MShares$50.8 Million0.08% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.09B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...